Teladoc Health to announce Q2 2026 results on July 29

1 min read Updated on 16 Jul 2026, 04:12 AM

Reviewed by

Jubin VScanX News Team

AI Summary

Teladoc Health Inc. will announce its Q2 2026 financial results on July 29, 2026, after market close. A conference call will follow at 5:00 p.m. ET to discuss the results. Access details for the call and webcast are provided for U.S. and international participants.

*this image is generated using AI for illustrative purposes only.

Teladoc Health Inc. will release its second quarter 2026 financial results on Wednesday, July 29, 2026, after the market closes. The company, a global leader in virtual care, will host a conference call to review the results at 5:00 p.m. ET on the same day. Investors can access the call by dialing 833-461-5787 for U.S. participants and using meeting ID # 478 236 923. International participants can find global dial-in numbers on the company's investor relations website.

Conference Call Access Details

A live audio webcast of the conference call will be available online. The replay will be accessible shortly after the call concludes and will remain available for approximately 90 days. The webcast and replay can be found at the company's events and presentations page.

Access Method	Details
U.S. Dial-in	833-461-5787
Meeting ID	478 236 923
International Dial-in	Available on company website
Webcast Link	Available on company website

About Teladoc Health

Teladoc Health delivers and orchestrates care across patients, care providers, platforms, and partners. The company works with health plans, employers, providers, health systems, and consumers to enable access, drive outcomes, extend provider capacity, and lower costs.

What key performance indicators will investors be focusing on during the Q2 2026 earnings call?

How might Teladoc's financial results impact the broader telehealth sector's market sentiment?

What strategic initiatives or partnerships could Teladoc announce to drive future growth?

Read Next Article

Teladoc shares fall 1.94% as Walmart partnership gains focus

1 min read Updated on 08 Jul 2026, 09:08 PM

Reviewed by

Anirudha BScanX News Team

Add as a preferred
source on Google

AI Summary

Teladoc Health Inc. shares declined 1.94% to $9.33 as investors examined the implications of its partnership with Walmart. The collaboration offers virtual care services, including urgent care, dermatology, and nutrition, through Walmart's Better Care Services platform for $89 per visit. The integration builds on a prior mental health service launch and aims to expand access to affordable virtual care.

*this image is generated using AI for illustrative purposes only.

Teladoc Health Inc. shares fell 1.94% to $9.33 as investors focused on the company's partnership with Walmart to expand virtual care access. The collaboration integrates Teladoc's services into Walmart's Better Care Services platform, offering customers insured and cash-pay options for virtual urgent care, dermatology, and nutrition services. The partnership aims to reduce friction in accessing healthcare by embedding Teladoc's clinical practice into Walmart's retail ecosystem.

Partnership Details

Under the agreement, Walmart customers can access Teladoc's 24/7 care for common conditions, dermatology consultations, and one-on-one nutrition support for a cash-pay price of $89 per visit. Prescriptions can be sent to a pharmacy, including Walmart, with same-day delivery available in many locations. The integration builds on a previous collaboration launched in January, which introduced Teladoc's BetterHelp mental health offering on Walmart's platform.

Service Offerings

Service Type	Description
Virtual Urgent Care	24/7 care for common conditions
Dermatology	Virtual consultations
Nutrition	One-on-one support
Mental Health	BetterHelp offering (launched January)

Kelly Bliss, Teladoc Health's President of U.S. Group Health, emphasized the strategic value of the partnership. "Walmart is where millions of Americans already go for everyday needs, and now, getting care from Teladoc Health can be part of that same experience," Bliss said. "By removing friction and meeting people where they are, virtual care becomes something people choose first, not just something they can access."

How will this partnership impact Teladoc's customer acquisition costs compared to traditional direct-to-consumer marketing?

Will the cash-pay model of $89 per visit be sustainable in the long term, or could pricing pressure arise from competitors?

Could this collaboration pave the way for similar integrations with other major retailers, expanding Teladoc's market reach?